Synthesis of silver nanoparticle-decorated hydroxyapatite nanocomposite with combined bioactivity and antibacterial properties.
Animals
Anti-Bacterial Agents
/ chemical synthesis
Bone Substitutes
/ chemical synthesis
Chickens
Coated Materials, Biocompatible
/ chemical synthesis
Durapatite
/ chemistry
Materials Testing
Metal Nanoparticles
/ chemistry
Microbial Sensitivity Tests
Microscopy, Electron, Transmission
Nanocomposites
/ chemistry
Prostheses and Implants
Silver
/ chemistry
Staphylococcus aureus
/ drug effects
Journal
Journal of materials science. Materials in medicine
ISSN: 1573-4838
Titre abrégé: J Mater Sci Mater Med
Pays: United States
ID NLM: 9013087
Informations de publication
Date de publication:
23 Aug 2021
23 Aug 2021
Historique:
received:
30
11
2020
accepted:
09
07
2021
entrez:
24
8
2021
pubmed:
25
8
2021
medline:
28
1
2022
Statut:
epublish
Résumé
Combination of bioactive material such as hydroxyapatite (HAp) with antibacterial agents would have great potential to be used as bone implant materials to avert possible bacterial infection that can lead to implant-associated diseases. The present study aimed to develop an antibacterial silver nanoparticle-decorated hydroxyapatite (HAp/AgNPs) nanocomposite using chemical reduction and thermal calcination approaches. In this work, natural HAp that was extracted from chicken bone wastes is used as support matrix for the deposition of silver nanoparticles (AgNPs) to produce HAp/AgNPs nanocomposite. XRD, FESEM-EDX, HRTEM, and XPS analyses confirmed that spherical AgNPs were successfully synthesized and deposited on the surface of HAp particles, and the amount of AgNPs adhered on the HAp surface increased with increasing AgNO
Identifiants
pubmed: 34426879
doi: 10.1007/s10856-021-06590-y
pii: 10.1007/s10856-021-06590-y
pmc: PMC8382650
doi:
Substances chimiques
Anti-Bacterial Agents
0
Bone Substitutes
0
Coated Materials, Biocompatible
0
Silver
3M4G523W1G
Durapatite
91D9GV0Z28
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106Informations de copyright
© 2021. The Author(s).
Références
J Pharm Bioallied Sci. 2013 Jun;5(Suppl 1):S125-7
pubmed: 23946565
Bioact Mater. 2019 May 20;4:196-206
pubmed: 31193406
Acta Biomater. 2019 Jan 15;84:414-423
pubmed: 30500448
J Mater Sci Mater Med. 2019 Jan 28;30(2):19
pubmed: 30689050
Stem Cells Int. 2018 Aug 2;2018:9643721
pubmed: 30154869
J Mater Sci Mater Med. 2015 Jul;26(7):215
pubmed: 26194976
Int J Mol Sci. 2019 Feb 17;20(4):
pubmed: 30781560
J Tissue Eng. 2018 Jun 04;9:2041731418776819
pubmed: 29899969
Mater Sci Eng C Mater Biol Appl. 2020 May;110:110735
pubmed: 32204045
Mater Sci Eng C Mater Biol Appl. 2020 Dec;117:111310
pubmed: 32919671
J Biomed Mater Res A. 2007 Mar 1;80(3):581-91
pubmed: 17031822
Nanomedicine (Lond). 2017 Nov;12(22):2771-2785
pubmed: 28967828
Mater Sci Eng C Mater Biol Appl. 2015 Oct;55:497-505
pubmed: 26117782
Mater Sci Eng C Mater Biol Appl. 2014 Feb 1;35:36-42
pubmed: 24411349
Dent Clin North Am. 2017 Oct;61(4):689-711
pubmed: 28886764
Mater Sci Eng C Mater Biol Appl. 2016 May;62:183-9
pubmed: 26952413
Mater Sci Eng C Mater Biol Appl. 2013 Apr 1;33(3):1395-402
pubmed: 23827587
J Mater Sci Mater Med. 2019 Feb 12;30(2):21
pubmed: 30747333
Heliyon. 2020 Aug 28;6(8):e04747
pubmed: 32913906
Biomed Res Int. 2013;2013:916218
pubmed: 23509801
Int J Nanomedicine. 2020 Apr 17;15:2555-2562
pubmed: 32368040
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:706-712
pubmed: 29853142